Elon Musk reacts to post claiming Chandrayaan-3's budget less than 'Interstellar'. Check out
Hours before the Chandraayan-3 completed its soft landing on the Moon, Tesla chief and the world's richest man, Elon Musk, responded to a post on X (formerly Twitter) that said the cost of the Indian Space Research Organisation (ISRO)'s mission is less than the budget of the Christopher Nolan directorial film 'Interstellar'.
In his reaction to the post, Musk said the mission is "good for India".
The post said that while the budget for India's moon mission is $75 million, the makers of Interstellar - starring Matthew McConaughey - spent $165 million on the project.
Kinda crazy when you realize India's budget for Chandrayaan-3 ($75M) is less than the film Interstellar ($165M)😯🚀 #Chandrayaan3 #moonlanding pic.twitter.com/r2ejJWbKwJ
— Newsthink (@Newsthink) August 21, 2023
In a game-changing feat in India's space exploration, the country's lunar mission Chandrayaan-3 successfully soft-landed on the South Polar region of the moon on Wednesday as a nation of 1.4 billion people erupted in joy and pride ending an anxious wait for the moment.
The scientists of ISRO burst into joy in the control room in Chennai, joining a proud nation, as chairman S Somanat said: "India is now on the moon."
IBNS
Senior Staff Reporter at Northeast Herald, covering news from Tripura and Northeast India.
Related Articles
Belly fat bombshell: Why your waistline matters more than BMI for heart failure risk
A new research suggests that measures of excess weight around the waist (central obesity or visceral fat) may increase the risk of heart failure primarily due to inflammation, according to findings presented at the American Heart Association’s EPI|Lifestyle Scientific Sessions 2026.
Shocking: Nearly 5 million children still die before age 5 every year — Here’s why
An estimated 4.9 million children died before their fifth birthday in 2024, including 2.3 million newborns, according to new United Nations estimates released on Tuesday – highlighting a worrying slowdown in global progress on child survival.
AstraZeneca India secures CDSCO approval for Durvalumab in advanced liver cancer
AstraZeneca Pharma India Ltd. (AZPIL) has announced that the Central Drugs Standard Control Organisation (CDSCO) has granted approval for an additional indication of Durvalumab.
Too hot to move? Study warns climate change may trigger mass inactivity and deaths
Rising global temperatures due to climate change could push millions of people into physical inactivity by 2050, potentially leading to hundreds of thousands of premature deaths and billions of dollars in lost productivity, according to a modelling study published in The Lancet Global Health.
Latest News
BJP fields RSS loyalist in Tripura bypoll, names late MLA son for Nagaland seat
RG Kar victim’s mother set to enter Bengal polls as BJP candidate
‘Will defeat Mamata Banerjee by 25,000 votes’: Suvendu Adhikari ups the stakes in Bhabanipur
Who is Bhumika Shrestha, Nepal’s first transgender woman lawmaker?
